학술논문

Patient reported outcomes (PROs) among patients with metastatic castration-resistant prostate cancer (mCRPC) by homologous recombination repair mutations (HRRm) gene clusters: Findings from the phase 3 TALAPRO-2 study cohort 2.
Document Type
Article
Source
Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p109-109, 235p
Subject
Language
ISSN
0732183X